Agreement enables development of genome-based therapies to protect against heart disease in adults

Through a new license, Harvard lab’s innovations in genome engineering might solve the organ transplant shortage

Harvard innovations enable the correction of single-base mutations in DNA with unprecedented precision and efficiency

Technique has potential to help reverse the most common type of disease-associated mutations